VanEck Associates’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
151,468
-4,923
-3% -$52.6K ﹤0.01% 1068
2026
Q1
$1.74M Buy
156,391
+31,362
+25% +$399K ﹤0.01% 1013
2025
Q4
$2.05M Buy
125,029
+88,834
+245% +$1.38M ﹤0.01% 987
2025
Q3
$484K Buy
+36,195
New +$428K ﹤0.01% 1197
2025
Q1
Sell
-16,148
Closed -$205K 1403
2024
Q4
$205K Buy
+16,148
New +$213K ﹤0.01% 1229
2024
Q3
Sell
-44,510
Closed -$564K 1401
2024
Q2
$564K Buy
44,510
+32,365
+266% +$560K ﹤0.01% 1057
2024
Q1
$275K Buy
12,145
+781
+7% +$18.3K ﹤0.01% 1133
2023
Q4
$282K Buy
+11,364
New +$222K ﹤0.01% 1122
2022
Q4
Sell
-23,850
Closed -$301K 1452
2022
Q3
$301K Buy
+23,850
New +$418K ﹤0.01% 967

Other funds holding PATH

VanEck Associates's PATH Position: Q2 2026 in Review

VanEck Associates reduced its UiPath (PATH) stake by 3.1% in Q2 2026, selling an estimated $52.6K and leaving 151,468 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

VanEck Associates first reported a position in PATH in Q3 2022 and has held it in 9 quarters since. The position peaked at $2.05M in Q4 2025. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • VanEck Associates held 151,468 shares of UiPath worth $1.65M as of Q2 2026.
  • VanEck Associates sold 4,923 UiPath shares in Q2 2026, an estimated $52.6K.
  • UiPath made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1068 holding.
  • VanEck Associates first reported a position in UiPath in Q3 2022 and has held it in 9 quarters since.
  • VanEck Associates's UiPath position peaked at $2.05M in Q4 2025.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.